Patents by Inventor Mahesh Kumar Verma

Mahesh Kumar Verma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thiophene compounds, process for synthesis and use thereof
    Patent number: 11739082
    Abstract: The present invention relates to novel thiophene compounds of general Formula I, and their stereoisomers (diastereoisomers, enantiomers), pure or mixed, racemic mixtures, geometrical isomers, tautomers, pharmaceutically acceptable salts, hydrates, solvates, solid forms and mixtures thereof along with process for their preparation. The present invention discloses compounds that are useful in the treatment and prevention of autoimmune diseases.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: August 29, 2023
    Assignee: Ahammune Biosciences Private Limited
    Inventors: Kashinath Komirishetty, Mahesh Kumar Verma, Parul Ganju, Sudhanand Prasad
  • NOVEL IMIDAZOLE COMPOUNDS, PROCESS FOR THE SYNTHESIS AND USES THEREOF
    Publication number: 20210380538
    Abstract: The present invention relates to novel pharmaceutical agents and the process of preparation thereof. The present invention discloses compounds of general formula I, and the process of their preparation. The compounds of the invention are useful in the treatment and prevention of diseases related to cellular stress mediated immune deregulation and loss of homeostasis also including autoimmune diseases, cancers, metabolic, dermatological, cardiovascular and neurodegenerative diseases.
    Type: Application
    Filed: November 1, 2019
    Publication date: December 9, 2021
    Inventors: Mahesh Kumar VERMA, Kashinath KOMIRISHETTY, Parul GANJU, Sudhanand PRASAD, Annie RICHHARIA, Sanket Sanjay SHETE
  • PROCESS FOR PREPARING A POTENT THIAZOLE COMPOUND, PHARMACEUTICAL FORMULATION AND USES THEREOF
    Publication number: 20210275502
    Abstract: The present invention relates to a process for preparing N-[2-[2-(4-chlorophenyl)-4-thiazolyl] ethyl]-butanamide. The present invention further relates to a pharmaceutical formulation and the use of said pharmaceutical formulation consisting of N-[2-[2-(4-chlorophenyl) -4-thiazolyl]ethyl]-butanamide or pharmaceutically acceptable salts thereof as active compound for the treatment and prevention of autoimmune diseases and diseases involving skin immunology, skin autoimmune diseases and pigmentation disorders.
    Type: Application
    Filed: April 26, 2019
    Publication date: September 9, 2021
    Inventors: Parul GANJU, Sudhanand PRASAD, Mahesh Kumar VERMA, Kashinath KOMIRISHETTY, Annie RICHHARIA
  • NOVEL THIOPHENE COMPOUNDS, PROCESS FOR SYNTHESIS AND USE THEREOF
    Publication number: 20200255417
    Abstract: The present invention relates to novel thiophene compounds of general Formula I, and their stereoisomers tures, geometrical isomers, tautomers, pharmaceutically acceptable salts, hydrates, solvates, solid forms and mixtures thereof along with process for their preparation. The present invention discloses compounds that are useful in the treatment and prevention of autoimmune diseases.
    Type: Application
    Filed: August 31, 2018
    Publication date: August 13, 2020
    Applicant: AHAMMUNE BIOSCIENCES PRIVATE LIMITED
    Inventors: Kashinath KOMIRISHETTY, Mahesh Kumar VERMA, Parul GANJU, Sudhanand PRASAD
  • Use of TAK1 Inhibitor to Achieve Glycemic Control in Mammals
    Publication number: 20140154263
    Abstract: The present invention relates to use of inhibitors of TAK-1 for the production of pharmaceutical agents to achieve glycemic control in mammals and which are therefore useful in the treatment of certain disorders that can be prevented or treated by inhibition of this enzyme.
    Type: Application
    Filed: December 5, 2013
    Publication date: June 5, 2014
    Applicant: Connexios Life Sciences Pvt. Ltd.
    Inventors: Anup Mammen Oommen, Mahesh Kumar Verma, Urvashi Bahadur, Swapnika Ramu